Corporate responsibility investor group touts support of first-year resolutions over executive pay, drug pricing

18th June 2018 Uncategorised 0

Investors at five drugmakers supported resolutions asking for more info about the link between drug prices and executive pay, but the tally didn’t pass 30% at any of the companies.

More: Corporate responsibility investor group touts support of first-year resolutions over executive pay, drug pricing
Source: fierce